DTCC Picks IBM, Axoni, R3 to Develop Distributed-Ledger Solution for Derivatives Processing

IBM and Axoni to develop DLT-based replacement for existing Trade Information Warehouse; R3 to act in advisory role.

Chris Childs, CEO of DTCC Deriv/SERV

The project aims to develop a distributed-ledger technology (DLT) framework to "re-platform" the DTCC's existing Trade Information Warehouse (TIW), which automates record-keeping, lifecycle events and payment management for approximately $11 trillion of cleared and bilateral credit derivatives.

Chris Childs, CEO of DTCC Deriv/SERV, tells WatersTechnology that the TIW is regarded by the industry as the "gold copy record" of credit default swap (CDS) contracts for around 95 percent of the global

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

If you already have an account, please sign in here.

Interop tech buys time for buy-side fixed-income traders

A few buy-side traders and portfolio managers spearheading a drive for greater interoperability are reaping the rewards of increased workplace efficiency. Is interoperability the fixed-income panacea the buy side has been looking for?

GenAI and HFT: A competitive edge?

Timing is critical in the capital markets. IBM researchers say genAI’s predictive abilities in combination with AI/ML models can translate into profitable HFT opportunities.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here